SOFTBANK

Oracle's Larry Ellison says AI-driven cancer vaccine could be coming soon as Donald Trump announces a $500 billion investment

Ellison explained that tiny tumour fragments can circulate in a person’s blood, allowing for the possibility of early cancer detection through blood tests. AI could be used to analyze these tests and identify cancer early on. Once the cancerous tumour is gene-sequenced, an individualized vaccine could be created for each patient. Using AI, the mRNA vaccine could be produced robotically in just 48 hours, offering rapid and personalized treatment.